Modulating Immunosuppression in the Intrapleural Space of Malignant Pleural Mesothelioma and Predictive Biomarkers to Guide Treatment Decisions.
Pacific Mesothelioma Center, Pacific Heart, Lung and Blood Institute, Los Angeles, California. Electronic address: rwong@phlbi.org.
Raymond M
RM
Wong
D015415:Biomarkers / Q000378:metabolism*; D003661:Decision Support Techniques; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000378:metabolism; D008654:Mesothelioma / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000378:metabolism; D000086002:Mesothelioma, Malignant; D016066:Pleural Effusion, Malignant / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000378:metabolism; D010997:Pleural Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000378:metabolism; D011237:Predictive Value of Tests
D015415:Biomarkers; D007166:Immunosuppressive Agents